Fertility
Frontiers

Have you associated a “healthy baby” with PGT-A’s purpose? It’s time to reconsider—don’t miss this interview featuring an outstanding genetic counselor! In this episode of Fertility Frontiers, we dive deep into the complexities of PGT-A with Meaghan Doyle, a certified genetic counselor and founder of DNAide Genetic Counselling. Key Takeaways: 1️⃣ PGT-A is a screening tool, not a diagnostic one, aimed at prioritizing embryos for transfer based on potential for ongoing pregnancy—not predicting a child's health. 2️⃣ Many patients misunderstand PGT-A's purpose, often thinking it's a guarantee of a healthy baby. 3️⃣ True informed consent is crucial—patients deserve tailored counseling to navigate the nuances of results, like mosaicism and aneuploidy. 💡 Meaghan envisions a future where labs undergo blinded, non-selection trials to validate and refine PGT-A reporting, ensuring every decision is guided by robust clinical significance. Tune in to hear her candid insights on improving patient care and advancing genetic counseling in fertility treatments! #PGTA #GeneticCounseling #FertilityFrontiers #IVF #InformedConsent #ReproductiveMedicine

In this episode, we sit down with Dr. Jacques Cohen—pioneering embryologist and CSO at Conceivable Life Sciences—for an expansive conversation on the future of IVF labs. From the development of automated micromanipulation tools to the rise of AI, Dr. Cohen unpacks decades of innovation and what's coming next. 🎯 Key insights: • Why the fusion of engineering and embryology sparks major breakthroughs. • What automation actually means in an IVF lab—and how far we are from full autonomy. • The real risk of AI startups in IVF, and why embryologists must evolve. This is one of the most thought-provoking episodes yet. Watch the full episode now and join the conversation. 📱 Follow @b.rodriguezalonso_phd on Instagram for more. #FertilityFrontiers #Embryology #Automation #IVF #AI #conceivable #JacquesCohen #ReproductiveMedicine #Fertility #Infertility

Dr. Juergen Liebermann discusses his research on ultra-fast vitrification and warming protocols. Traditionally, cryopreserving and thawing embryos could take up to 20 minutes, with vitrification requiring 9 minutes and warming 11 minutes. The new protocol has dramatically reduced this time, cutting vitrification to just 5 minutes and warming to only 1 minute. This advancement enhances the efficiency of the process, achieving a remarkable 70% reduction in total time!

Dr. Oleksii Barash dives into the science, challenges, and future of Preimplantation Genetic Testing for Aneuploidies (PGT-A). While PGT-A is widely used as a screening tool in reproductive medicine, Dr. Barash emphasizes its limitations, including challenges in standardization and inherent screening constraints. He also highlights the importance of individualized decisions, particularly for mosaic embryos, tailored to each patient’s risk tolerance. Despite its procedural risks and high costs, Dr. Barash’s data shows that PGT-A often offers significant benefits, even for younger patients. Stay tuned to Fertility Frontiers for more expert insights on PGT-A and its evolving role in reproductive medicine! #FertilityFrontiers #PGTA #ReproductiveMedicine #Embryology

In this episode of Fertility Frontiers, we explore the complexities of PGT-A with Dr. Mina Popovic, the Scientific Director of the Eugin Group and a Professor at Ghent University. Key Takeaways: 1️⃣ PGT-A helps streamline the IVF journey by preventing predictable failures. In doing so, PGT-A may reduce the time needed to achieve a pregnancy and minimize the emotional and financial burdens associated with multiple failed transfers. 2️⃣ We urgently need better standardization across laboratories, clearer guidelines for interpretation and reporting, and greater transparency in how results are presented. 3️⃣ Looking to the future, the most valuable advances won’t necessarily be in improving PGT-A itself, but in developing complementary tools that could aid in the positive selection of embryos. Credits: Beatriz Rodríguez Alonso, PhD @b.rodriguezalonso_phd x Fertility Frontiers #PGTA #FertilityFrontiers #IVF #aneuploidy #mosaicism #embryology #embryoselection #genetics

In this episode of Fertility Frontiers, we have Rita Vassena, the co-founder and CEO of Fecundis Lab. Fecundis lab aims to improve IVF efficiency by redefining sperm capacitation. Her team developed HyperSperm, a technology that better simulates the female reproductive environment, enhancing sperm's fertilization ability and resulting in a 63% increase in embryonic development in clinical trials.

Debbie Venier, Co-Founder of WEST - World Embryology Skills and Training, addresses a pressing challenge in the fertility field: the shortage of well-trained embryologists in the U.S. With approximately 2,500 embryologists nationwide and the field growing at 10% annually, nearly 40% of these professionals are nearing retirement. Many of these experts, who have dedicated decades to advancing fertility care, are leaving a significant gap as they transition out of the workforce. Debbie highlights the limitations of traditional on-the-job training, which often lacks the scientific depth and hands-on rigor needed for today’s rapidly evolving fertility labs. WEST’s mission is to develop a new generation of science-savvy embryologists who not only follow protocols but understand the science behind them. As automation and robotics become integral to fertility labs, critical thinking and scientific expertise will be key to maintaining the highest standards of care. Stay tuned to Fertility Frontiers for more insights from pioneers in reproductive medicine as we explore solutions to the industry’s biggest challenges! #FertilityFrontiers #EmbryologyTraining #ReproductiveMedicine

In this episode of Fertility Frontiers, Dr. Ramos Ibeas reviews the incredible journey that led to the creation of Teodoro, the first genetically modified lamb in Spain. This innovative research conducted at INIA marks a milestone in reproductive science. Teodoro is what in science is known as a "Knockout model", a powerful tool used by researchers to understand what specific genes do in living organisms. By "knocking out" specific genes, researchers can observe what happens when those genes are missing. If you imagine each gene as a part of a car's engine, knocking out a gene is like removing a specific part, such as the brakes or the steering wheel, to see what that part actually does when the car is running. Teodoro will help scientists study reproductive failures in farm animals and provide critical insights into human fertilization, offering hope for future advances in fertility treatments.

The last episode in our PGT-A series features Dr. Alyssa Snider, PhD in Genetics with specialized training in genetic counseling. Currently the Director of Clinical Genetics at Igenomix, part of the Vitrolife Group, Dr. Snider brings a wealth of expertise in reproductive genetics and a patient-centered approach to fertility care. In this episode, Dr. Snyder shares her insights into the complexities of PGT-A, addressing its potential and the challenges it presents. Highlights of our discussion include: • Strategies for integrating patient values and risk tolerance into personalized fertility care plans. • The role of genetic counseling in helping patients navigate complex decisions regarding PGT-A results. • Dr. Snider's emphasis on advocating for transparency when reporting mosaic results, empowering patients with accurate and comprehensive information. 👉 Follow Fertility Frontiers to continue the conversation as we explore the controversies, innovations, and ethical considerations surrounding PGT-A. #FertilityFrontiers #PGTA #ReproductiveGenetics #Embryology